新斯的明用于腹腔镜胃肠手术后拮抗残余肌松的临床研究

陈秋芬; 闵苏; 余畅; 律峰; 张雨晞

doi:10.16016/j.2097-0927.202211115

您当前的位置：

首页 >

文章列表页 >

新斯的明用于腹腔镜胃肠手术后拮抗残余肌松的临床研究

临床医学 | 更新时间：2026-01-09

- 新斯的明用于腹腔镜胃肠手术后拮抗残余肌松的临床研究
- Clinical application of neostigmine in antagonizing postoperative residual curarization after elective laparoscopic gastrointestinal surgery
- 陆军军医大学学报 2023年45卷第8期页码：825-834
- 作者机构：
  
  1.400016 重庆，重庆医科大学附属第一医院麻醉科
  2.252000 山东聊城，聊城市人民医院麻醉科
- 作者简介：
  
  [闵苏，E-mail：ms89011068@163.comMIN Su, E-mail: ms89011068@163.com
- 基金信息：
  
  重庆市卫生适宜技术推广项目(2021jstg026)
- DOI：10.16016/j.2097-0927.202211115
  中图分类号： R619;R655;R971.91
- 收稿：2022-11-16，
  
  修回：2022-12-13，
  
  纸质出版：2023-04-30
- 稿件说明：
移动端阅览
陈秋芬, 闵苏, 余畅, 等. 新斯的明用于腹腔镜胃肠手术后拮抗残余肌松的临床研究[J]. 陆军军医大学学报, 2023,45(8):825-834.

Qiufen CHEN, Su MIN, Chang YU, et al. Clinical application of neostigmine in antagonizing postoperative residual curarization after elective laparoscopic gastrointestinal surgery[J]. Journal of Army Medical University, 2023, 45(8): 825-834.
陈秋芬, 闵苏, 余畅, 等. 新斯的明用于腹腔镜胃肠手术后拮抗残余肌松的临床研究[J]. 陆军军医大学学报, 2023,45(8):825-834. DOI： 10.16016/j.2097-0927.202211115.

Qiufen CHEN, Su MIN, Chang YU, et al. Clinical application of neostigmine in antagonizing postoperative residual curarization after elective laparoscopic gastrointestinal surgery[J]. Journal of Army Medical University, 2023, 45(8): 825-834. DOI： 10.16016/j.2097-0927.202211115.

摘要

目的

探讨新斯的明的不同给药时机和剂量对于其拮抗腹腔镜胃肠手术患者全身麻醉恢复期内罗库溴铵残余肌松作用的效果的影响。

方法

本研究采用平行随机对照研究设计方案，选取2021年11月至2022年2月在重庆医科大学附属第一医院经腹腔镜下行胃肠择期手术患者220例，随机分为4组(每组55例)：4个成串刺激计数(train-of-four count，TOFC)=1时，给予0.04 mg/kg新斯的明+0.02 mg/kg阿托品组(A

组)；TOFC=1时，给予0.06 mg/kg新斯的明+0.03 mg/kg阿托品组(A

组)；4个成串刺激比值(train-of-four ratio，TOFr)=0.4时，给予0.04 mg/kg新斯的明+0.02 mg/kg阿托品组(B

组)；TOFr=0.4时，给予0.06 mg/kg新斯的明+0.03 mg/kg阿托品组(B

组)。记录并对比分析患者手术前的身体和生理特征、患者手术中的生理、用药、手术、麻醉、出血量以及苏醒和镇静等相关信息；监测并记录给予拮抗药物前后血流动力学参数值；对比分析从末次使用肌松药开始至肌松恢复到TOFC=1、TOFC=3、TOFr=0.4、TOFr=0.7及TOFr=1.0所需时间以及拔除气管导管后TOFr的变化。

结果

临床试验中剔除了18例患者，最终收集202例患者的数据进行统计分析。从末次应用罗库溴铵开始，A

、A

、B

和B

组肌松恢复至TOFr=1.0所需时间分别为94.53 min (95%

：92.84~96.23)、85.88 min (95%

：84.91~86.86)、75.08 min (95%

：72.95~77.20) 和68.30 min (95%

：66.53~70.07)，差异有统计学意义(

0.05)；拔管后除B

组外，A

、A

、B

组都有患者发生了术后肌松残余(postoperative residual curarization，PORC)。A

、A

、B

组的PORC发生率分别是14.29% (95%

：5.94%~27.24%)、7.84%(95%

：2.18%~18.88%)和1.92%(95%

：0.05%~10.26%)，与B

组相比，差异有统计学意义(

0.05)。

结论

对于在麻醉恢复期内的腹腔镜胃肠手术患者，在肌松自主恢复到TOFr=0.4时给予0.06 mg/kg新斯的明+0.03 mg/kg阿托品可快速拮抗罗库溴铵的残余肌松作用，减少PORC的发生。

Abstract

Objective

To investigate the clinical effects of the timing and dosage of neostigmine on its antagonistic effects on postoperative residual curarization (PORC) induced by rocuronium in patients undergoing laparoscopic gastrointestinal surgery during recovery of general anesthesia.

Methods

A total 220 patients undergoing elective laparoscopic gastrointestinal surgery in the First Affiliated Hospital of Chongqing Medical University from November 2021 to February 2022 were recruited in this study. They were randomly divided into 4 groups

with 55 patients in each group. After spontaneous muscle relaxation recovery to train-of-four count (TOFC)=1

the patients in groups A

and A

were intravenously given 0.04 mg/kg neostigmine +0.02 mg/kg atropine and 0.06 mg/kg neostigmine combined with 0.03 mg/kg atropine

respectively. In contrast

after spontaneous muscle relaxation recovery instead to train-of-four ratio (TOFr

)=0.4

the patients in groups B

and B

were intravenously given 0.04 mg/kg neostigmine +0.02 mg/kg atropine and 0.06 mg/kg neostigmine +0.03 mg/kg atropine

respectively. The physical and physiological characteristics of the patients before operation

and the physiological parameters

medication

operation

anesthesia

bleeding volume

awakening and sedation of the patients during operation were recorded and analyzed comparatively. Hemodynamic

changes before and after the administration of neostigmine were monitored and recorded. The durations from the last administration of muscle relaxant to different stages of muscle relaxation recovery

defined by the values of TOFC=1

TOFC=3

TOFr=0.4

TOFr=0.7 and TOFr=1.0

were analyzed comparatively. The changes in TOFr after extubation were also analyzed comparatively.

Results

Eighteen patients were excluded from the trial

and

consequently

202 patients were finally enrolled. The A

and B

groups took 94.53 (95%

: 92.84~96.23)

85.88 (95%

: 84.91~86.86)

75.08 (95%

: 72.95~77.20) and 68.30 min (95%

: 66.53~70.07)

respectively

to recover to TOFr=1.0 from the last administration of rocuronium bromide

and significant difference was seen in recovery time among the 4 groups (all

0.05). In every group except B

there was at least 1 patient suffering from PORC

with an incidence of 14.29% (95%

: 5.94%~27.24%)

7.84% (95%

: 2.18%~18.88%) and 1.92% (95%

: 0.05%~10.26%)

respectively in the other 3 groups in turn

which was significantly different from that in B

group (

0.05).

Conclusion

For patients undergoing laparoscopic gastrointestinal surgery during recovery of general anesthesia

administration of 0.06 mg/kg neostigmine+0.03 mg/kg atropine when TOFr=0.4 can accelerate the recovery of muscle tone and reduce the incidence of PORC after extubation.

关键词

Keywords

references

CHEN A T, PATEL A, MCKECHNIE T, et al . Sugammadex in co lorectal surgery: a systematic review and meta-analysis[J ] . J Surg Res, 2022, 270: 221-229. DOI: 10.1016/j.jss.2021.09.026.

MOON T S, REZNIK S, PAK T, et al . Sugammadex versus neostigmine for reversal of rocuronium-induced neuromuscular blockade: a randomized, double-blinded study of thoracic surgical patients evaluating hypoxic episodes in the early postoperative period[J ] . J Clin Anesth, 2020, 64: 109804. DOI: 10.1016/j.jclinane.2020.109804.

MCMAHON A J, O'DWYER P J, BAXTER J N. Laparoscopic interventions in the gut: yesterday, today, and tomorrow[J]. Dig Dis, 1996, 14(1): 14-26. DOI: 10.1159/000171536.

RICHEBÉ P, BOUSETTE N, FORTIER L P. A narrative review on the potential benefits and limitations of deep neuromuscular blockade[J]. Anaesth Crit Care Pain Med, 2021, 40(4): 100915. DOI: 10.1016/j.accpm.2021.100915.

BOGGETT S, CHAHAL R, GRIFFITHS J, et al . A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine[J ] . Anaesthesia, 2020, 75(9): 1153-1163. DOI: 10.1111/anae.15094.

ÖZDEMIR-VAN BRUNSC HOT D M D, BRAAT A E, VAN DER JAGT M F P, et al . Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy[J ] . Surg Endosc, 2018, 32(1): 245-251. DOI: 10.1007/s00464-017-5670-2.

王婷婷, 孙申, 王琦, 等. 腹腔镜与开腹手术中单次输注罗库溴铵或顺式阿曲库铵后神经肌肉阻滞时间的比较[J]. 复旦学报(医学版), 2017, 44(2): 150-154, 174. DOI: 10.3969/j.issn.1672-8467.2017.02.004.

WANG T T, SUN S, WANG Q, et al . Comparison of the duration of neuromuscular blockade following a single bolus dose of rocuronium or cisatracurium in laparoscopic gynaecological surgery and conventional open surgery[J ] . Fudan Univ J Med Sci, 2017, 44(2): 150-154, 174. DOI: 10.3969/j.issn.1672-8467.2017.02.004.

高航. 妇科腹腔镜手术与开腹手术术后罗库溴铵残余作用比较[J]. 检验医学与临床, 2013, 10(11): 1453-1455. DOI: 10.3969/j.issn.1672-9455.2013.11.069.

GAO H. Comparison of residual effects of rocuronium after laparoscopic surgery and open surgery[J]. Lab Med Clin, 2013, 10(11): 1453-1455. DOI: 10.3969/j.issn.1672-9455.2013.11.069.

BRULL S J, KOPMAN A F. Current status of neuromuscular reversal and monitoring: challenges and opportunities[J]. Anesthesiology, 2017, 126(1): 173-190. DOI: 10.1097/ALN.0000000000001409.

KIRSCHNIAK A, POINTNER R, GRANDERATH F A. Laparoscopic toupet-fundoplication[J]. Zentralbl Chir, 2013, 138(4): 397-399. DOI: 10.1055/s-0033-1350636.

陈浩聪, 陆志俊. 舒更葡糖钠不良反应的研究进展[J]. 国际麻醉学与复苏杂志, 2021, 42(1): 53-57. DOI: 10.3760/cma.j.cn321761-20200504-00194.

CHEN H C, LU Z J. Research progress on adverse effects of sugammadex[J]. Int J Anesthesiol Resusc, 2021, 42(1): 53-57. DOI: 10.3760/cma.j.cn321761-20200504-00194.

MAURIN M P, MULLINS R A, SINGH A, et al . A systematic review of complications related to laparoscopic and laparoscopic-assisted procedures in dogs[J ] . Vet Surg, 2020, 49(Suppl 1): O5-O14. DOI: 10.1111/vsu.13419.

ORIHARA M, TAKAZAWA T, HORIUCHI T, et al . Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study[J ] . Br J Anaesth, 2020, 124(2): 154-163. DOI: 10.1016/j.bja.2019.10.016.

闻大翔, 怀晓蓉. 肌肉松弛药及其拮抗剂的研究进展[J]. 药学进展, 2017, 41(5): 346-354.

WEN D X, HUAI X R. Research progress in muscle relaxants and their antagonists[J]. Prog Pharm Sci, 2017, 41(5): 346-354.

高佳栋, 陈海, 肖海峰, 等. 新斯的明拮抗老年患者米库氯铵肌松残余的临床效果[J]. 临床麻醉学杂志, 2017, 33(3): 252-256.

GAO J D, CHEN H, XIAO H F, et al . Effect of antagonism of neostigmine on residual neuromuscular blockade from mivacurium chloride in the elderly patients[J ] . J Clin Anesthesiol, 2017, 33(3): 252-256.

KHETERPAL S, VAUGHN M T, DUBOVOY T Z, et al . Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis[J ] . Anesthesiology, 2020, 132(6): 1371-1381. DOI: 10.1097/ALN.0000000000003256.

中华医学会麻醉学分会. 2017版中国麻醉学指南与专家共识[M]. 北京: 人民卫生出版社, 2017: 34-35.

Anesthesiology Branch of Chinese Medical Association. Chinese anesthesiology guide and expert consensus (2017)[M]. Beijing: People's Health Publishing House, 2017: 34-35.

陈伯銮. 临床麻醉药理学[M]. 北京: 人民卫生出版社, 2000: 340-342.

CHEN B L. Anesthetic pharmacology. [M]. Beijing: People's Health Publishing House, 2000: 340-342

刘力, 闵苏, 李炜, 等. 七氟醚和异氟醚对罗库溴铵阻滞大鼠骨骼肌成人型乙酰胆碱受体的影响[J]. 中华麻醉学杂志, 2011(7): 805-808.

LIU L, MIN S, LI W, et al . Effects of sevoflurane and isoflurane on blockade of adult type nicotinic acetylcholine receptors of skeletal muscle of rats by rocuronium[J ] . Chin J Anesth, 2011(7): 805-808. DOI: 10.3760/cma.j.issn.0254-1416.2011.07.008

BROENS S J L, BOON M, MARTINI C H, et al . Reversal of partial neuromuscular block and the ventilatory response to hypoxia: a randomized controlled trial in healthy volunteers[J ] . Anesthesiology, 2019, 131(3): 467-476. DOI: 10.1097/ALN.0000000000002711.

CARRON M, ANDREATTA G, PESENTI E, et al . Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study[J ] . Perioper Med, 2022, 11(1): 3. DOI: 10.1186/s13741-021-00231-2.

李世勇, 罗爱林. 2021英国麻醉医师协会《麻醉和恢复期间监测标准推荐意见》解读[J]. 临床外科杂志, 2022, 30(1): 36-39. DOI: 10.3969/j.issn.1005-6483.2022.01.012.

LI S Y, LUO A L. Interpretation of recommendations for monitoring standards during anaesthesia and recovery by the British society of anesthesiologists(2021)[J]. J Clin Surg, 2022, 30(1): 36-39. DOI: 10.3969/j.issn.1005-6483.2022.01.012.

KIM K S, CHEONG M A, LEE H J, et al . Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia[J ] . Anesth Analg, 2004, 99(4): 1080-1085. DOI: 10.1213/01.ANE.0000130616.57678.80.

KIRKEGAARD H, HEIER T, CALDWELL J E. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block[J]. Anesthesiology, 2002, 96(1): 45-50. DOI: 10.1097/00000542-200201000-00013.

郭曲练, 姚尚龙. 临床麻醉学[M]. 4版. 北京: 人民卫生出版社, 2016: 104-105.

GUO Q L, YAO S L. Clinical anesthesiology[M]. 4th Edition. Beijing: People's Health Publishing House, 2016: 104-105

FUCHS-BUDER T, MEISTELMAN C, ALLA F, et al . Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine[J ] . Anesthesiology, 2010, 112(1): 34-40. DOI: 10.1097/ALN.0b013e3181c53863.

KOPMAN A F, EIKERMANN M. Antagonism of non-depolarising neuromuscular block: current practice[J]. Anaesthesia, 2009, 64(Suppl 1): 22-30. DOI: 10.1111/j.1365-2044.2008.05867.x.

MCLEA N D J, DIAZ-GIL D, FARHAN H N, et al . Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications[J ] . Anesthesiology, 2015, 122(6): 1201-1213. DOI: 10.1097/ALN.0000000000000674.

FORTIER L P, MCKEEN D, TURNER K, et al . The RECITE study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade[J ] . Anesth Analg, 2015, 121(2): 366-372. DOI: 10.1213/ANE.0000000000000757.

邓小明, 姚尚龙, 于布为. 现代麻醉学[M]. 4版. 北京: 人民卫生出版社, 2014: 876-886.

DENG X M, YAO S L, YU B W. Modern anesthesiology[M]. 4th Edition. Beijing: People's Health Publishing House, 2014: 876-886.

邓小明. 米勒麻醉学. 8版. [M]. 北京: 北京大学医学出版社, 2016: 898-927.

DENG X M. Millers anesthesia[M]. 8th edition. Beijing: Peking University Medical Press, 2016: 898-927.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据